| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Izabela Fulone, Marcus Tolentino Silva, Luciane Cruz Lope. Gender differences in the use of atypical antipsychotics in early-onset schizophrenia: a nationwide population-based study in Brazil. BMC psychiatry. vol 21. issue 1. 2021-08-06. PMID:34187418. |
the use of atypical antipsychotics for the treatment of schizophrenia and other mental disorders in populations under 18 years of age is increasing worldwide. |
2021-08-06 |
2023-08-13 |
Not clear |
| Izabela Fulone, Marcus Tolentino Silva, Luciane Cruz Lope. Gender differences in the use of atypical antipsychotics in early-onset schizophrenia: a nationwide population-based study in Brazil. BMC psychiatry. vol 21. issue 1. 2021-08-06. PMID:34187418. |
the aim of this study was to investigate gender differences in the use of atypical antipsychotics in patients with early-onset schizophrenia (eos) assisted by the public health system in brazil. |
2021-08-06 |
2023-08-13 |
Not clear |
| Jia Hong Liu, Nan Chen, Yan Hong Guo, Xiao Ni Guan, Jun Wang, Dong Wang, Mei Hong Xi. Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia. Journal of psychiatric research. vol 140. 2021-08-05. PMID:34144444. |
previous studies have demonstrated that patients with schizophrenia (sz) have greater rate of metabolic disorder as compared with the control population, which likely be the consequence of use of atypical antipsychotics. |
2021-08-05 |
2023-08-13 |
Not clear |
| Paula Soria-Chacartegui, Gonzalo Villapalos-García, Pablo Zubiaur, Francisco Abad-Santos, Dora Kolle. Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Frontiers in pharmacology. vol 12. 2021-08-03. PMID:34335273. |
olanzapine, aripiprazole and risperidone are atypical antipsychotics or neuroleptics widely used for schizophrenia treatment. |
2021-08-03 |
2023-08-13 |
Not clear |
| Tengfei Yuan, Shaoting Wang, Juan Le, Yan L. Effects of Atypical Antipsychotics on Neuroactive Vitamins in Patients With Schizophrenia. Journal of clinical pharmacology. vol 60. issue 10. 2021-07-30. PMID:32428979. |
effects of atypical antipsychotics on neuroactive vitamins in patients with schizophrenia. |
2021-07-30 |
2023-08-13 |
Not clear |
| Aditi Kadakia, Brenna L Brady, Huan Huang, Carole Dembek, G Rhys Williams, Justine M Ken. The Incidence and Economic Burden of Extrapyramidal Symptoms in Patients with Schizophrenia Treated with Atypical Antipsychotics. CNS spectrums. vol 26. issue 2. 2021-07-23. PMID:34127088. |
the incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with atypical antipsychotics. |
2021-07-23 |
2023-08-13 |
Not clear |
| Kristen M Ward, Kyle Burghardt, A Zarina Kraal, Andrew Jaeger, Larisa Yeomans, Cora McHugh, Alla Karnovsky, Kathleen A Stringer, Vicki L Ellingro. Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics. Frontiers in psychiatry. vol 12. 2021-07-15. PMID:34113268. |
genetic and metabolite variability in one-carbon metabolism applied to an insulin resistance model in patients with schizophrenia receiving atypical antipsychotics. |
2021-07-15 |
2023-08-13 |
Not clear |
| Rocco F Marotta, Frank D Buono, Amir Garakani, Eric Collins, Brianna Cerrito, David Rowe David Row. The effects of augmenting clozapine with oxytocin in schizophrenia: An initial case series. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 32. issue 2. 2021-06-18. PMID:32343282. |
debilitating symptoms of schizophrenia often persist after sustained treatment with atypical antipsychotics. |
2021-06-18 |
2023-08-13 |
Not clear |
| Anastasiia S Boiko, Irina A Mednova, Elena G Kornetova, Valeria I Gerasimova, Alexander N Kornetov, Anton J M Loonen, Nikolay A Bokhan, Svetlana A Ivanov. Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics. Pharmaceuticals (Basel, Switzerland). vol 14. issue 5. 2021-06-15. PMID:34065135. |
cytokine level changes in schizophrenia patients with and without metabolic syndrome treated with atypical antipsychotics. |
2021-06-15 |
2023-08-13 |
Not clear |
| Anastasiia S Boiko, Irina A Mednova, Elena G Kornetova, Valeria I Gerasimova, Alexander N Kornetov, Anton J M Loonen, Nikolay A Bokhan, Svetlana A Ivanov. Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics. Pharmaceuticals (Basel, Switzerland). vol 14. issue 5. 2021-06-15. PMID:34065135. |
the present study aims at comparing the change in cytokine levels in schizophrenia patients treated with atypical antipsychotics, with or without metabolic syndrome (mets). |
2021-06-15 |
2023-08-13 |
Not clear |
| Valéria de Almeida, Guilherme L Alexandrino, Adriano Aquino, Alexandre F Gomes, Michael Murgu, Henrik Dobrowolny, Paul C Guest, Johann Steiner, Daniel Martins-de-Souz. Changes in the blood plasma lipidome associated with effective or poor response to atypical antipsychotic treatments in schizophrenia patients. Progress in neuro-psychopharmacology & biological psychiatry. vol 101. 2021-06-04. PMID:32304808. |
atypical antipsychotics are widely used to manage schizophrenia symptoms. |
2021-06-04 |
2023-08-13 |
Not clear |
| Xue-Lin Chao, Shu-Zhen Jiang, Jian-Wen Xiong, Jin-Qiong Zhan, Bo Wei, Chun-Nuan Chen, Yuan-Jian Yan. Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics. Current medical science. vol 40. issue 3. 2021-05-18. PMID:32681260. |
changes of serum insulin-like growth factor-2 response to negative symptom improvements in schizophrenia patients treated with atypical antipsychotics. |
2021-05-18 |
2023-08-13 |
Not clear |
| Xue-Lin Chao, Shu-Zhen Jiang, Jian-Wen Xiong, Jin-Qiong Zhan, Bo Wei, Chun-Nuan Chen, Yuan-Jian Yan. Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics. Current medical science. vol 40. issue 3. 2021-05-18. PMID:32681260. |
here we conducted a prospective observation trial to investigate the effects of atypical antipsychotics on serum igf-2 level and its relationship with clinical improvements in schizophrenia patients. |
2021-05-18 |
2023-08-13 |
Not clear |
| Xue-Lin Chao, Shu-Zhen Jiang, Jian-Wen Xiong, Jin-Qiong Zhan, Bo Wei, Chun-Nuan Chen, Yuan-Jian Yan. Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics. Current medical science. vol 40. issue 3. 2021-05-18. PMID:32681260. |
collectively, our findings demonstrated changes of serum igf-2 response to improvements of negative symptoms in schizophrenia patients treated with atypical antipsychotics, suggesting that serum igf-2 might be a treatment biomarker for schizophrenia. |
2021-05-18 |
2023-08-13 |
Not clear |
| Gulshan Begum, Stanley Nkemjika, Olaniyi Olayinka, Tolu Olupona, Ayodeji Jolayem. Clozapine Response for Vocal Tics in Schizophrenic Patients: A Case Report With Literature Review. Cureus. vol 13. issue 3. 2021-04-29. PMID:33907647. |
additionally, evidence in the literature has shown that typical and atypical antipsychotics are effective for the treatment of tic disorders in patients who are diagnosed with schizophrenia and other psychiatric illnesses. |
2021-04-29 |
2023-08-13 |
Not clear |
| Samantha Alvarez-Herrera, Raúl Escamilla, Oscar Medina-Contreras, Ricardo Saracco, Yvonne Flores, Gabriela Hurtado-Alvarado, José Luis Maldonado-García, Enrique Becerril-Villanueva, Gilberto Pérez-Sánchez, Lenin Pavó. Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics. Frontiers in endocrinology. vol 11. 2021-04-01. PMID:32373066. |
atypical antipsychotics (aap) or second-generation antipsychotics are the clinical option for schizophrenia treatment during acute psychoses, but they are also indicated for maintenance during lifetime, even though they are being used for other psychiatric conditions in clinical practice such as affective disorders and autism spectrum disorder, among others. |
2021-04-01 |
2023-08-13 |
Not clear |
| Wenjuan Yu, Jingjing Huang, Sidi He, Lei Zhang, Yifeng Shen, Huafang L. Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study. General psychiatry. vol 34. issue 1. 2021-03-03. PMID:33644688. |
atypical antipsychotics as first-line drugs have been used in patients with schizophrenia in china and abroad. |
2021-03-03 |
2023-08-13 |
Not clear |
| Mehran Zarghami, Seyed Davood Hoseini, Arash Kazemi, Forouzan Elyas. Concurrent Hepatotoxicity and Neutropenia Induced by Clozapine. Archives of Iranian medicine. vol 23. issue 2. 2021-01-06. PMID:32061077. |
clozapine is known as one of the atypical antipsychotics which is placed in the second line of medical treatment for schizophrenia due to its hematologic complications. |
2021-01-06 |
2023-08-13 |
Not clear |
| Giuseppe Caruso, Margherita Grasso, Annamaria Fidilio, Fabio Tascedda, Filippo Drago, Filippo Carac. Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia. Pharmaceuticals (Basel, Switzerland). vol 13. issue 12. 2020-12-29. PMID:33322693. |
opposite to haloperidol, second-generation antipsychotics (or atypical antipsychotics) such as risperidone, clozapine, and olanzapine exert a strong antioxidant activity in experimental models of schizophrenia by rescuing the antioxidant system, with an increase in superoxide dismutase and glutathione (gsh) serum levels. |
2020-12-29 |
2023-08-13 |
Not clear |
| Yanyan Hou, Jiaheng Xie, Yanbo Yuan, Zhang Cheng, Xue Han, Lei Yang, Xin Yu, Chuan Sh. Neurocognitive effects of atypical antipsychotics in patients with first-episode schizophrenia. Nordic journal of psychiatry. vol 74. issue 8. 2020-11-20. PMID:32496921. |
neurocognitive effects of atypical antipsychotics in patients with first-episode schizophrenia. |
2020-11-20 |
2023-08-13 |
Not clear |